Zdrowie i gospodarka · 09/03/2022

FDA Withdraws Approval of Potaba Oral Preparations

The FDA has withdrawn all outstanding hearing requests for Potaba oral preparations, effectively canceling the approval of a new drug application. The agency determined that the products were not shown to be effective under the prescribed conditions.